PMC:7274968 / 3131-3341
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T5 | 159-167 | Body_part | denotes | androgen | http://purl.org/sig/ont/fma/fma83375 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T31 | 11-12 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T32 | 135-137 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T33 | 138-140 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T34 | 145-146 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 159-167 | Chemical | denotes | androgen | http://purl.obolibrary.org/obo/CHEBI_50113 |
T3 | 191-194 | Chemical | denotes | ADT | http://purl.obolibrary.org/obo/CHEBI_40799 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T28 | 0-210 | Sentence | denotes | The use of a neoadjuvant treatment up to an expected resolution of the peak of the pandemic was recommended by the 82% of the centers (18/22) if a concomitant androgen deprivation treatment (ADT) was indicated. |